Newsletters

JULY 2025 ISSUE OF APPLIED POLICY INSIGHT

Read newsletter

In the July 2025 edition of  Insight, CMO Bill Rogers reflects upon  the integration of advanced medical imaging into clinical practice during his career. We look at the first month of the FDA’s Elsa program, examine how states are addressing…

JUNE 2025 ISSUE OF APPLIED POLICY INSIGHT

Read more

In the June 2025 edition of Insight, President and CEO Jim Scott explains the importance of our commitment to Improving Lives. Emma Hammer presents a summary of the White House budget and Sabrina Luther considers the Trump administration’s efforts to reduce…

MAY 2025 ISSUE OF APPLIED POLICY INSIGHT

Read newsletter

In the June 2025 edition of Insight, President and CEO Jim Scott explains our commitment to Improving Lives. Emma Hammer presents a summary of the White House budget and Sabrina Luther examines the Trump Administration’s move away from animal testing…

APRIL 2025 ISSUE OF APPLIED POLICY INSIGHT

Read newsletter

In the April 2025 edition of Insight, Sampat Nidadavolu discusses the importance of Minimum Life Requirements in durable medical equipment, Caitlyn Bernard describes how Applied Policy is able to offer such rapid analysis of federal rules, and our Dr. William…

MARCH 2025 ISSUE OF APPLIED POLICY INSIGHT

Read newsletter

In the March 2025 edition of Insight, we share insights and experiences from current and past Applied Policy interns, welcome Linda Rouse O’Neill as Vice President of Health Policy, and look at the differences between MedPAC and MACPAC. Plus: updates…

FEBRUARY 2025 ISSUE OF APPLIED POLICY INSIGHT

Read newsletter

In the February 2025 edition of Insight, Applied Policy President and CEO Jim Scott reflects on the value of new approaches to existing and emerging challenges in the healthcare sector. We also look at the work of the Advisory Committee…

JANUARY 2025 ISSUE

Read newsletter

Applied Policy Insight begins 2025 with a policy primer for the coming months. We discuss the budget reconciliation process, which Republicans will use to advance President-elect Trump’s economic agenda in Congress. We also consider the return of Schedule F and…

December 2024

Read newsletter

How our commitment to saving lives has driven a record of success for clients, an analysis of the Part B drugs subject to inflation rebates for 2024, and a look at our 2024 stories with an eye toward changes under…

November 2024

Read newsletter

Possible changes in health policy under a new presidential administration in 2025; the implications of a forthcoming rule from HHS, the Departments of Labor and Treasury on copay accumulators and maximizers; and the future of CMS’s Best Price ‘Stacking’ proposal.

October 2024

Read newsletter

The possibility of MAC consolidations, a summary of CMS’s education session on the Transitional Coverage for Emerging Technologies (TCET) pathway and the latest on another delay of PAMA implementation.

September 2024

Read newsletter

 An examination of compounding pharmacies and the anniversary of the two-midnight rule.

August 2024

Read newsletter

The response of non-diabetes advocacy groups to MEDCAC’s consideration of diabetes devices, a look at states’ responses to healthcare issues, and a primer on patent thickets.